Recombinant Adenovirus Expressing Von Hippel-Lindau-Mediated Cell Cycle Arrest Is Associated with the Induction of Cyclin-Dependent Kinase Inhibitor p27Kip1

This publication has 14 references indexed in Scilit:

• The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
  Proceedings of the National Academy of Sciences, 1998
• Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells
  Oncogene, 1998
• The Molecular Basis of Von Hippel-Lindau Disease
  Molecular Medicine, 1997
• Isolation and characterization of the full-length 3′ untranslated region of the human von Hippel-Lindau tumor suppressor gene
  Human Genetics, 1996
• Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
  Proceedings of the National Academy of Sciences, 1996
• Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.
  Proceedings of the National Academy of Sciences, 1996
• Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein
  Science, 1995
• Tumour suppression by the human von Hippel-Lindau gene product
  Nature Medicine, 1995
• Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.
  Proceedings of the National Academy of Sciences, 1995
• Identification of the von Hippel-Lindau (VHL) Gene
  JAMA, 1995